Urine Mir-21-5P As a Potential Biomarker for Predicting Effectiveness of Tadalafil in Benign Prostatic Hyperplasia

Tomoaki Tanaka1 Department of Urology, Osaka City University Graduate School of Medicine, Osaka, Osaka, JapanCorrespondence[email protected]

Akinori Minami1 Department of Urology, Osaka City University Graduate School of Medicine, Osaka, Osaka, Japan

Kouichiro Tashiro2 Department of Urology, Meijibashi Hospital, Matsubara, Osaka, Japan;3 Department of Urology, Yoshida Hospital, Hirakata, Osaka, Japan

Naomasa Yoshida3 Department of Urology, Yoshida Hospital, Hirakata, Osaka, Japan

Akira Tohda4 Department of Urology, Moriguchi Ikuno Memorial Hospital, Moriguchi, Osaka, Japan

Yasuo Yamakoshi5 Department of Urology, Ishikiriseiki Hospital, Higashiosaka, Osaka, Japan

Ryoji Yasumoto6 Yasumoto Nephrology-Urology Clinic, Osaka, Osaka, Japan

Shozo Sugita7 Department of Urology, Ohno Memorial Hospital, Osaka, Osaka, Japan

Tatsuya Nakatani1 Department of Urology, Osaka City University Graduate School of Medicine, Osaka, Osaka, Japan

show all

Urine Mir-21-5P As a Potential Biomarker for Predicting Effectiveness of Tadalafil in Benign Prostatic Hyperplasia

Supplementary Material For: Supplemental figure 1 The ROC analysis of the predictive powers of urine miR-126-5p and miR-155-5p

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Urine Mir-21-5P As a Potential Biomarker for Predicting Effectiveness of Tadalafil in Benign Prostatic Hyperplasia

Supplementary Material For: Supplemental figure 1 The ROC analysis of the predictive powers of urine miR-126-5p and miR-155-5p

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date